Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe D Strain

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Annals of Pharmacotherapy|March 2, 2006
Sodium oxybate for cataplexyMichael D Lemon, Joe D Strain, Debra K Farver
Clinical Pharmacology : Advances and Applications|February 1, 2012
A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapyJoe D Strain, Debra K Farver, James R Clem
Risk Management and Healthcare Policy|February 8, 2012
Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?James R Clem, Joe D Strain, Debra K Farver
Journal of Clinical Pharmacology|April 11, 2017
Brivaracetam: An Adjunctive Treatment for Partial-Onset SeizuresJohn A Kappes, William J Hayes, Joe D Strain, et al.
Therapeutics and Clinical Risk Management|February 12, 2009
New advances in the treatment of Clostridium difficile infection (CDI)Dennis D Hedge, Joe D Strain, Jodi R Heins, et al.
Drug Design, Development and Therapy|November 19, 2009
Indiplon in the management of insomniaMichael D Lemon, Joe D Strain, Annie M Hegg, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Annals of Pharmacotherapy|March 2, 2006
Sodium oxybate for cataplexyMichael D Lemon, Joe D Strain, Debra K Farver
Clinical Pharmacology : Advances and Applications|February 1, 2012
A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapyJoe D Strain, Debra K Farver, James R Clem
Risk Management and Healthcare Policy|February 8, 2012
Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?James R Clem, Joe D Strain, Debra K Farver
Journal of Clinical Pharmacology|April 11, 2017
Brivaracetam: An Adjunctive Treatment for Partial-Onset SeizuresJohn A Kappes, William J Hayes, Joe D Strain, et al.
Therapeutics and Clinical Risk Management|February 12, 2009
New advances in the treatment of Clostridium difficile infection (CDI)Dennis D Hedge, Joe D Strain, Jodi R Heins, et al.
Drug Design, Development and Therapy|November 19, 2009
Indiplon in the management of insomniaMichael D Lemon, Joe D Strain, Annie M Hegg, et al.
Pageof 1